NCT06051188

Brief Summary

The goal of this clinical trial is to compare flow-controlled ventilation (FCV) and pressure-controlled ventilation (PCV) in patients with moderate to severe acute respiratory distress syndrome on the intensive care unit. The main questions it aims to answer are:

  • Is the mechanical power during flow-controlled ventilation lower than during pressure-controlled ventilation
  • To gain more understanding about other physiological effects and potential benefits of flow-controlled ventilation in comparison to pressure-controlled ventilation (o.a. the end-expiratory lung volume and homogeneity of ventilation). Participants will be randomized between two ventilation mode sequences, being 90 minutes of FCV followed by 90 minutes of PCV or vice versa.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 7, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

September 12, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 22, 2023

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

December 1, 2023

Status Verified

November 1, 2023

Enrollment Period

1.6 years

First QC Date

September 7, 2023

Last Update Submit

November 30, 2023

Conditions

Keywords

Flow-controlled ventilationARDSElectrical Impedance TomographyMechanical Power

Outcome Measures

Primary Outcomes (1)

  • Mechanical power

    Difference in mechanical power in J/min after 90 minutes of flow-controlled ventilation and 90 minutes of pressure-controlled ventilation

    90 minutes

Secondary Outcomes (10)

  • End-expiratory lung volume

    30 minutes

  • Dissipated energy

    90 minutes

  • Airway pressures

    30 and 90 minutes

  • Transpulmonary pressures

    30 and 90 minutes

  • Minute volume

    30 and 90 minutes

  • +5 more secondary outcomes

Study Arms (2)

FCV-PCV

EXPERIMENTAL

90 minutes of flow-controlled ventilation followed by 90 minutes of pressure-controlled ventilation.

Device: Flow-controlled ventilation

PCV-FCV

EXPERIMENTAL

90 minutes of pressure-controlled ventilation followed by 90 minutes of flow-controlled ventilation.

Device: Flow-controlled ventilation

Interventions

Flow-controlled ventilation (FCV)

FCV-PCVPCV-FCV

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • Provided written informed consent
  • Undergoing controlled mechanical ventilation via an endotracheal tube
  • Meeting all criteria of the Berlin definition of ARDS
  • Hypoxic respiratory failure within 1 week of a known clinical insult or new or worsening respiratory symptoms
  • Bilateral opacities on X-ray or CT-scan not fully explained by effusions, lobar/lung collapse (atelectasis), or nodules
  • Respiratory failure not fully explained by cardiac failure or fluid overload.
  • Oxygenation: moderate ARDS P/F ratio between 101-200 mmHg, severe ARDS PF ratio ≤ 100mmHg, both with PEEP ≥ 5 cmH2O.
  • Intubated ≤72 hours

You may not qualify if:

  • Severe sputum stasis or production requiring frequent bronchial suctioning (more than 5 times per nurse shift)
  • Untreated pneumothorax (i.e., no pleural drainage)
  • Hemodynamic instability defined as a mean arterial pressure below 60mmHg not responding to fluids and/or vasopressors or a noradrenalin dose \>0.5mcrg/kg/min
  • High (\>15 mmHg) or instable (an increase in sedation or osmotherapy is required) intracranial pressure
  • An inner tube diameter of 6mm or less
  • Intubated \> 72 hours
  • Anticipating withdrawal of life support and/or shift to palliation as the goal of care
  • Inability to perform adequate electrical impedance tomography (EIT) measurements with, e.g.:
  • Have a thorax circumference inappropriate for EIT-belt
  • Thoracic wounds, bandages or deformities preventing adequate fit of EIT-belt
  • Recent (\<7 days) pulmonary surgery including pneumonectomy, lobectomy or lung transplantation
  • ICD device present (potential interference with proper functioning of the EIT device and ICD device)
  • Excessive subcutaneous emphysema
  • Contra-indications for nasogastric tube or inability to perform adequate transpulmonary pressure measurements with, e.g.:
  • Recent esophageal surgery
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maasstad Hospital

Rotterdam, South Holland, 3079DZ, Netherlands

RECRUITING

Related Publications (1)

  • van Oosten JP, Francovich JE, Weller D, Rietdijk W, Goedendorp N, Somhorst P, den Uil CA, Gommers D, Jonkman AH, Endeman H. Flow-controlled ventilation versus pressure-controlled ventilation in moderate to severe ARDS patients: a randomized crossover physiological study. Intensive Care Med Exp. 2025 Dec 24;13(1):137. doi: 10.1186/s40635-025-00847-4.

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Rik Endeman, Dr

    Erasmus Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Julien van Oosten, MD

CONTACT

Annemijn Jonkman, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Randomized crossover physiological pilot study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 7, 2023

First Posted

September 22, 2023

Study Start

September 12, 2023

Primary Completion

May 1, 2025

Study Completion

May 1, 2026

Last Updated

December 1, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations